Without that regulatory milestone, the compound remains outside the CMS formulary review process entirely
As research into GLP-1 RAs continues, these drugs could become a cornerstone in a comprehensive, multi-faceted approach to managing diabetes complicationshelping patients not only control their blood sugar but also protect their kidneys and heart
Holding that discipline is what ensures first do no harm remains central, particularly in health-conscious individuals where potential benefit is uncertain and avoidable risk matters more
1e and Supplementary Fig
In addition to impaired glucose metabolism, extensive clinical, preclinical, and epidemiological data have linked lipid metabolic dysfunction to AD risk
J Clin Neurophysiol 36(6):443451 Obrador E, Salvador-Palmer R, Lpez-Blanch R, Jihad-Jebbar A, Valls SL, Estrela JM (2021) The link between oxidative stress, redox status, bioenergetics and mitochondria in the pathophysiology of ALS